Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Strope JD"'
Autor:
Lee KY; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Beatson EL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Knechel MA; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sommer ER; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Napoli GC; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Risdon EN; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Leon AF; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Depaz RD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Strope JD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Price DK; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
Journal of Cancer [J Cancer] 2024 Jan 01; Vol. 15 (3), pp. 615-622. Date of Electronic Publication: 2024 Jan 01 (Print Publication: 2024).
Autor:
Barbier RH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., McCrea EM; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Lee KY; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Strope JD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Risdon EN; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Price DK; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA. figgw@mail.nih.gov.; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. figgw@mail.nih.gov.
Publikováno v:
Scientific reports [Sci Rep] 2021 May 24; Vol. 11 (1), pp. 10765. Date of Electronic Publication: 2021 May 24.
Autor:
Schmidt KT; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Strope JD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Huitema ADR; Department Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Sissung TM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Price DK; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. figgw@helix.nih.gov.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 May; Vol. 20 (5), pp. 915-924. Date of Electronic Publication: 2021 Feb 25.
Autor:
Lochrin SE; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Turkbey B; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Gasmi B; Translational Surgical Pathology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Schmidt K; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Strope JD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Sissung TM; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Price DK; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Cordes L; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Markolovic S; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Wood BJ; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Pinto PA; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., McKinney YL; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Shih JH; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA., Levy E; Radiology and Imaging Sciences, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Madan R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Dahut W; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA., Choyke PL; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Merino M; Translational Surgical Pathology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. figgw@mail.nih.gov.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, MD, 20892, USA. figgw@mail.nih.gov.
Publikováno v:
Scientific reports [Sci Rep] 2021 Mar 11; Vol. 11 (1), pp. 5662. Date of Electronic Publication: 2021 Mar 11.
Autor:
Strope JD; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA., Lochrin SE; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA., Sissung TM; Clinical Pharmacology Program, National Cancer Institute, National Institute of Health, Bethesda, USA., Kem R; Cancer Therapy Evaluation Program, National Cancer Institute, National Institute of Health, Bethesda, USA., Chandrasekaran P; National Institutes of Aging, National Institute of Health, Bethesda, USA., Sharon E; Cancer Therapy Evaluation Program, National Cancer Institute, National Institute of Health, Bethesda, USA., Price DK; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA., Uldrick TS; Division of Medical Oncology, Vaccine and Infectious Disease Division, Division of Global Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Yarchoan R; HIV/AIDS Malignancy Branch, National Cancer Institute, National Institute of Health, Bethesda, USA., Figg WD; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA.
Publikováno v:
AIDS reviews [AIDS Rev] 2020 Oct 26; Vol. 23 (1), pp. 13-27.
Autor:
Strope JD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: figgw@mail.nih.gov.
Publikováno v:
Seminars in oncology [Semin Oncol] 2020 Oct; Vol. 47 (5), pp. 335-340. Date of Electronic Publication: 2020 Jun 17.
Autor:
Beedie SL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland., Huang PA; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Harris EM; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Strope JD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mahony C; School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland., Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Vargesson N; School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland., Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2020 Sep; Vol. 34 (9), pp. 11395-11404. Date of Electronic Publication: 2020 Jul 17.
Autor:
Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Strope JD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Pharmacotherapy [Pharmacotherapy] 2020 Aug; Vol. 40 (8), pp. 857-868.
Autor:
Strope JD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., PharmD CHC; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2020 Jul; Vol. 60 (7), pp. 801-807. Date of Electronic Publication: 2020 May 21.
Autor:
Hawley JE; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Pan S; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Lopez-Bujanda ZA; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.; Graduate Program in Pathobiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Strope JD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Aggen DH; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Dallos MC; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Lim EA; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Stein MN; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Hu J; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Drake CG; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.; Department of Urology, Columbia University Medical Center, New York, New York.
Publikováno v:
The Prostate [Prostate] 2020 Mar; Vol. 80 (4), pp. 336-344. Date of Electronic Publication: 2020 Jan 03.